Aug 30 (Reuters) - The U.S. Food and Drug Administration granted expanded approval to Emergent BioSolutions' (EBS.N), opens new tab smallpox vaccine for use in people at high risk of mpox infection.

An FDA-approved vaccine for smallpox and mpox is effective but causes side effects. The other requires multiple doses. An experimental single-dose vaccine uses the horsepox virus to harness the ...

It all started with an unremarkable trip to grandma’s house in 1970. But two days into the visit, something went terribly wrong. The 9-month-old grandson fell ill. First, a fever. Then, a nasty rash.

‘Pre-attack’ plan must account for numerous health risks of vaccine. WASHINGTON — Looming war with Iraq and growing concern over the threat of bioterrorism are moving federal officials to consider ...